FundedIQ
Biotechnology

PhoreMost: Funding, Investors & Team (Oct 2026)

PhoreMost is a drug discovery company located in Cambridge, UK that specializes in identifying new potential drug targets. By collaborating with a network of academic and industrial partners, the company aims to bring a variety of targeted therapies to market more efficiently and at a lower cost for patients.

www.phoremost.com LinkedIn Cambridge, United Kingdom 51-100 employees
Total raised
$12.0M
Rounds
1
Latest
Series B
Sep 2024

PhoreMost has raised $12.0M across 1 funding round on record, the most recent a Series B of $12.0M announced in Sep 2024.

That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

PhoreMost Company Profile and Key Stats

Total funding raised
$12.0M
across 1 round on record
Funding rounds on record
1
Latest funding round
Series B
$12.0M in Sep 2024
Employees
51-100
reported band
Headquarters
Cambridge, United Kingdom

Latest funding round on record: Sep 2024.

PhoreMost Funding Rounds

Date
Round
Amount
Series B
$12.0M

PhoreMost Founders and Leadership Team

Name
Role
Contact
Chris Torrance
Founder
Locked

Contact details for the PhoreMost team: 1 of 1 has an email address on file.

Start 14-day free trial →

PhoreMost Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.1M
5,352
$4.1M
4,401
$31M

PhoreMost's latest round of $12.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like PhoreMost in Biotechnology and Cambridge

Companies Similar to PhoreMost

R1 Therapeutics is a clinical‑stage biopharmaceutical company focused on discovering and developing new drug…

Series A $3.0M

The perfect package for any general surgical trainee or resident. Progress from beginner to advanced surgical…

Undisclosed round $9.3M

Argonaute RNA company research projects build on existing intellectual property.

Undisclosed round $1.8M

An innovative C elegans company that serves the biotech, nutrition, and other industries and fields of study…

Undisclosed round $1.8M

ViaNautis, previously known as SomaServe, was established in 2018 as a separate entity from UCL under the…

Undisclosed round $23.3M

Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of…

Series A $33.6M

Biodexa Pharmaceuticals is an international specialty pharmaceutical company focused on oncology and other…

Undisclosed round $3.5M

Concert Bio helps businesses create optimal microbial communities.

Undisclosed round $130k

RQ Bio is a biotechnology company that develops long-acting monoclonal antibodies against seasonal influenza…

Series A $113M

N4 Pharma is a drug reformulation company focused on developing and out licensing new versions of existing…

Undisclosed round $3.6M

Laverock Therapeutics is working on developing a system for suppressing genes, which can be used to create…

Undisclosed round $3.0M

Oak hill bio is a clinical-stage rare disease therapeutics company developing life-changing medicines.

Series A $32.5M

PhoreMost Funding FAQs

What does PhoreMost do?

PhoreMost is a drug discovery company located in Cambridge, UK that specializes in identifying new potential drug targets. By collaborating with a network of academic and industrial partners, the company aims to bring a variety of targeted therapies to market more efficiently and at a lower cost for patients.

How much funding has PhoreMost raised?

PhoreMost has raised $12.0M across 1 round on record. The most recent is a Series B of $12.0M announced in Sep 2024.

When did PhoreMost last raise funding?

PhoreMost's most recent funding round on record is a Series B of $12.0M, announced in Sep 2024.

Who founded PhoreMost?

FundedIQ lists Chris Torrance (Founder) at PhoreMost.

Where is PhoreMost headquartered?

PhoreMost is based in Cambridge, Cambridgeshire, United Kingdom.

How many employees does PhoreMost have?

PhoreMost is in the 51-100 employee band.

How does PhoreMost's funding compare to other Biotechnology startups?

PhoreMost's latest round of $12.0M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's PhoreMost Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for PhoreMost is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.